SCHEMBL23980608

SCHEMBL23980608

N#Cc1c(O)nc2c(c1O)CCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22440489 0.72 HTR2A (0.37) —
SCHEMBL30422289 0.71 HTR2C (0.34) —
SCHEMBL29479135 0.69 ALDH1A1 (0.39) —
SCHEMBL24373046 0.69 ALDH1A1 (0.39) —
SCHEMBL23465146 0.66 PARP1 (0.32) —
SCHEMBL24891788 0.63 HTT (0.46) —
SCHEMBL1497107 0.62 HTR2A (0.36) —
SCHEMBL30420972 0.62 HTR2A (0.33) —
SCHEMBL23979946 0.62 HTR2A (0.33) —
SCHEMBL21994455 0.62 PNMT (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021219072-A1 PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUND AS KRAS INHIBITOR 上海科州药物研发有限公司 (CN) 2021-11-04 — — WO disclosed
Send feedback